With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

Baron Funds mentioned Eli Lilly and Company (NYSE:LLY) in its Q2 2024 investor letter. Here is what the fund said: ...

Eli Lilly and Company’s LLY stock has risen 21.1% in ... In the past couple of years, it has received approvals for several new drugs like Kisunla, Omvoh and Jaypirca and witnessed pipeline ...

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

This new option helps millions of adults with obesity access the medicine they need, including those not Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley 22nd Annual Global ...

Sept 18 (Reuters) - Drugmaker Eli Lilly (LLY.N), opens new tab on Wednesday urged a federal ... In May 2023, a jury found the company liable for $61 million, which the judge tripled to $183 ...

Baron Funds mentioned Eli Lilly and Company (NYSE:LLY) in its Q2 2024 investor letter. Here is what the fund said: “In biopharmaceuticals, we remain bullish on the market opportunity for new ...

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use ... will be available in the next few weeks, the company said. Eczema, also known as atopic dermatitis ...

Eli Lilly has partnered with the AI-driven drug discovery startup company, Genetic Leap. The partnership centers on developing new drugs, particularly those targeting RNA, which attempt to treat ...

Earlier this year, Eli Lilly and Co. opened a new research and development center in Fort Point ... and EMD Serono decided to ...

The U.S. Food and Drug Administration has declined to approve Vanda Pharmaceuticals' drug to treat stomach paralysis symptoms ...